ZA876731B - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- ZA876731B ZA876731B ZA876731A ZA876731A ZA876731B ZA 876731 B ZA876731 B ZA 876731B ZA 876731 A ZA876731 A ZA 876731A ZA 876731 A ZA876731 A ZA 876731A ZA 876731 B ZA876731 B ZA 876731B
- Authority
- ZA
- South Africa
- Prior art keywords
- aluminium hydroxide
- ibuprofen
- therapeutic agents
- aluminium
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868623557A GB8623557D0 (en) | 1986-10-01 | 1986-10-01 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA876731B true ZA876731B (en) | 1988-03-14 |
Family
ID=10605072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA876731A ZA876731B (en) | 1986-10-01 | 1987-09-09 | Therapeutic agents |
Country Status (16)
Country | Link |
---|---|
US (1) | US4831058A (da) |
EP (1) | EP0264187B1 (da) |
JP (1) | JPS63101321A (da) |
KR (1) | KR950009090B1 (da) |
AT (1) | ATE58471T1 (da) |
AU (1) | AU594607B2 (da) |
CA (1) | CA1306686C (da) |
DE (1) | DE3766343D1 (da) |
DK (1) | DK503687A (da) |
ES (1) | ES2031904T3 (da) |
GB (1) | GB8623557D0 (da) |
GR (1) | GR3001284T3 (da) |
IE (1) | IE61062B1 (da) |
NZ (1) | NZ221962A (da) |
PT (1) | PT85829B (da) |
ZA (1) | ZA876731B (da) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3639038C2 (de) * | 1986-11-14 | 1997-02-06 | Helmut Dr Lukas | Verwendung von S-(+)-Ibuprofen zur schnellen Behandlung humaner Schmerzen |
IT1226549B (it) * | 1988-07-12 | 1991-01-24 | Resa Farma | Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose. |
US4916161A (en) * | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
DE3938227C1 (en) * | 1989-11-17 | 1991-05-02 | Dolorgiet Gmbh & Co Kg, 5205 St Augustin, De | Oral antiinflammatory and analgetic pharmaceutical compsn. - comprises magnesium ibuprofen dissolved in mixt. of water, propane-1,2-diol and glycerol |
CA2103443C (en) * | 1991-05-28 | 1998-12-22 | Robert P. Geyer | Chewable drug-delivery composition |
US5380535A (en) * | 1991-05-28 | 1995-01-10 | Geyer; Robert P. | Chewable drug-delivery compositions and methods for preparing the same |
US5605930A (en) * | 1991-10-21 | 1997-02-25 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for treating and preventing pathologies including cancer |
US5409709A (en) * | 1991-11-29 | 1995-04-25 | Lion Corporation | Antipyretic analgesic preparation containing ibuprofen |
US5288507A (en) * | 1992-07-29 | 1994-02-22 | Merck & Co., Inc. | Ibuprofen antacid combinations |
AU699192B2 (en) * | 1993-08-13 | 1998-11-26 | Bayer Corporation | Hydrolyzed gelatin as a flavor enhancer in a chewable tablet |
DE69425589T2 (de) * | 1993-12-10 | 2001-01-04 | Fujisawa Pharmaceutical Co., Ltd. | Kombiniertes antipyretisches und analgetisches arzneimittel |
IT1270239B (it) * | 1994-06-17 | 1997-04-29 | Zambon Spa | Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo |
US5639475A (en) * | 1995-02-03 | 1997-06-17 | Eurand America, Incorporated | Effervescent microcapsules |
DE19529862A1 (de) * | 1995-08-14 | 1997-02-20 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
GB9625589D0 (en) | 1996-12-10 | 1997-01-29 | Boots Co Plc | Therapeutic agents |
US6376481B2 (en) * | 1998-09-02 | 2002-04-23 | Mcneil-Ppc, Inc. | Sterol esters in tableted solid dosage forms |
US6740341B1 (en) | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
CA2351720C (en) * | 1998-11-25 | 2006-11-21 | Cima Labs Inc. | Taste masking rapid release coating system |
IE990159A1 (en) * | 1999-02-26 | 2000-09-20 | Fuisz Internat Ltd | Storage Stable Amoxycillin and Clavulanate Suspension Composition. |
JP5519890B2 (ja) * | 2001-02-28 | 2014-06-11 | エスエス製薬株式会社 | 経口用イブプロフェン製剤 |
ES2323264T3 (es) * | 2001-08-01 | 2009-07-10 | Novartis Ag | Composicion para enmascaramiento del sabor. |
CA2478411C (en) * | 2002-03-12 | 2010-09-28 | Bristol-Myers Squibb Company | Palatable oral suspension and method |
FR2850275B1 (fr) | 2003-01-24 | 2005-04-08 | Scherer Technologies Inc R P | Capsules molles a macher contenant une substance active a gout masque |
JP2009514857A (ja) * | 2005-11-02 | 2009-04-09 | テイコク ファーマ ユーエスエー インコーポレーテッド | 感覚器官的に許容されるイブプロフェン経口投与用製剤、該製剤の製法並びに使用法 |
EP2158913A1 (en) * | 2008-08-25 | 2010-03-03 | Ratiopharm GmbH | Pharmaceutical composition comprising N-[3-chhloro-4-[(3-fluorophenyl)methoxy]phenyl]6-(5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4-quinazolinamine |
JP5740896B2 (ja) * | 2009-10-27 | 2015-07-01 | ライオン株式会社 | 解熱鎮痛組成物 |
JP6140570B2 (ja) * | 2013-08-13 | 2017-05-31 | ライオン株式会社 | イブプロフェン含有錠剤及びその製造方法 |
US10821073B1 (en) | 2013-09-30 | 2020-11-03 | Make Ideas, LLC | Edible animal medicine container |
US9498433B1 (en) * | 2013-09-30 | 2016-11-22 | Make Ideas, LLC | Edible animal medicine container |
JP6877923B2 (ja) * | 2016-09-06 | 2021-05-26 | ライオン株式会社 | 内服用半固形製剤及びその製造方法 |
US11503806B1 (en) | 2018-06-12 | 2022-11-22 | Make Ideas Llc | Dog dental device with brushes extending through compressible outer shell |
HUE062682T2 (hu) * | 2018-11-16 | 2023-11-28 | Ssp Co Ltd | Ibuprofén tartalmú orális gyógyszerészeti készítmény |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636200A (en) * | 1969-06-09 | 1972-01-18 | Hoffmann La Roche | Pharmaceutical suspension |
CA992542A (en) * | 1971-03-22 | 1976-07-06 | Toshihisa Itaya | Tri-substituted aluminum salts or di-substituted aluminum salts of carboxyl group-containing, pharmaceutically effective compounds, and process for preparation thereof |
GB1435892A (en) * | 1972-07-04 | 1976-05-19 | Beecham Group Ltd | Aluminium complexes of guaiphenesin |
GB1451541A (en) * | 1974-02-16 | 1976-10-06 | Lilly Co Eli | Aluminum salts of substituted phenyl-alkanoic acids and pharma ceutical suspensions prepared therefrom core-sampling device for obtaining a core sample from a loose |
CA1062721A (en) * | 1975-12-15 | 1979-09-18 | Anthony A. Sinkula | Propionic acid derivatives |
US4145440A (en) * | 1977-08-18 | 1979-03-20 | The Upjohn Company | Liquid suspension of an aluminum salt of ibuprofen |
US4361580A (en) * | 1980-06-20 | 1982-11-30 | The Upjohn Manufacturing Company | Aluminum ibuprofen pharmaceutical suspensions |
SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
EP0094116A3 (en) * | 1982-05-06 | 1984-08-01 | The Procter & Gamble Company | Therapeutic granules |
IT1175941B (it) * | 1984-02-16 | 1987-08-12 | Stabil Bioterapico Farmachim | Sali d'alluminio mono, bi e trisostituiti degli acidi aril-alcanoici e composizioni farmaceutiche che li contengono |
AT385894B (de) * | 1985-10-04 | 1988-05-25 | Basem Dr Nashef | Schlauchfoermige sonde |
US4753800A (en) * | 1985-10-04 | 1988-06-28 | Warner-Lambert Company | Medicament adsorbates and their preparation |
US4716033A (en) * | 1986-03-27 | 1987-12-29 | Warner-Lambert Company | Medicament adsorbates with surfactant and their preparation |
-
1986
- 1986-10-01 GB GB868623557A patent/GB8623557D0/en active Pending
-
1987
- 1987-09-08 IE IE240087A patent/IE61062B1/en not_active IP Right Cessation
- 1987-09-09 ZA ZA876731A patent/ZA876731B/xx unknown
- 1987-09-09 EP EP87307943A patent/EP0264187B1/en not_active Expired - Lifetime
- 1987-09-09 DE DE8787307943T patent/DE3766343D1/de not_active Expired - Fee Related
- 1987-09-09 ES ES198787307943T patent/ES2031904T3/es not_active Expired - Lifetime
- 1987-09-09 AT AT87307943T patent/ATE58471T1/de not_active IP Right Cessation
- 1987-09-25 DK DK503687A patent/DK503687A/da not_active Application Discontinuation
- 1987-09-28 NZ NZ221962A patent/NZ221962A/xx unknown
- 1987-09-29 CA CA000548177A patent/CA1306686C/en not_active Expired - Fee Related
- 1987-09-29 PT PT85829A patent/PT85829B/pt not_active IP Right Cessation
- 1987-09-30 AU AU79218/87A patent/AU594607B2/en not_active Ceased
- 1987-09-30 US US07/102,863 patent/US4831058A/en not_active Expired - Lifetime
- 1987-09-30 JP JP62247766A patent/JPS63101321A/ja active Pending
- 1987-09-30 KR KR1019870010896A patent/KR950009090B1/ko not_active IP Right Cessation
-
1991
- 1991-01-03 GR GR91400006T patent/GR3001284T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR950009090B1 (ko) | 1995-08-14 |
GB8623557D0 (en) | 1986-11-05 |
DE3766343D1 (de) | 1991-01-03 |
IE872400L (en) | 1989-03-08 |
DK503687D0 (da) | 1987-09-25 |
EP0264187A1 (en) | 1988-04-20 |
NZ221962A (en) | 1990-03-27 |
DK503687A (da) | 1988-04-02 |
IE61062B1 (en) | 1994-09-21 |
KR880004807A (ko) | 1988-06-27 |
PT85829B (pt) | 1990-07-31 |
US4831058A (en) | 1989-05-16 |
GR3001284T3 (en) | 1992-08-26 |
PT85829A (en) | 1987-10-01 |
JPS63101321A (ja) | 1988-05-06 |
ATE58471T1 (de) | 1990-12-15 |
EP0264187B1 (en) | 1990-11-22 |
CA1306686C (en) | 1992-08-25 |
AU7921887A (en) | 1988-04-14 |
ES2031904T3 (es) | 1993-01-01 |
AU594607B2 (en) | 1990-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA876731B (en) | Therapeutic agents | |
CH680983C1 (da) | ||
PL318649A1 (en) | Preparation to be administered by inhalation | |
AU645555B2 (en) | Improvements in or relating to the treatment of gastrointestinal disorders | |
CA2093806A1 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
AU6060896A (en) | Oral 1alpha-hydroxyprevitamin D | |
ES2006649A6 (es) | Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma. | |
AU644094B2 (en) | Medicaments | |
DE59410151D1 (de) | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe | |
CA2136404A1 (fr) | Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale | |
IL102814A0 (en) | Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them | |
CA2202397A1 (en) | Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders | |
NZ225950A (en) | Calcium citrate malate in the molar ratio of 6:2:3; pharmaceutical compositions | |
AU3318389A (en) | Azelastine-containing medicaments with controlled release of the active substance | |
GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
GB1487334A (en) | Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof | |
CA2078869A1 (en) | Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use | |
DE3380294D1 (en) | Pharmaceutical compositions in oral dosage form | |
GR3031360T3 (en) | Composition based on ibuprofen, for oral usage | |
MY111155A (en) | Medicaments |